Timo Minssen
Professor
JUR Center for Advanced Studies in Bioscience Innovation Law
Karen Blixens Plads 16
2300 København S
German court blocks approval of European patent system
20/03/2020
1 Media contribution
Press/Media: Press / Media
In Conversation With... Sara Gerke and Timo Minssen
23/06/2020
1 Media contribution
Press/Media: Press / Media
Influencer Dies After Drinking Pesticide During Livestream As Viewers Encouraged Her Suicide
Karen Celedonia, Marcelo Corrales Compagnucci, Michael Lowery Wilson & Timo Minssen
18/10/2021
1 item of Media coverage
Press/Media: Press / Media
Interview for WHO: Regulating digital health
01/04/2020
1 Media contribution
Press/Media: Press / Media
Interview on the Role of Patents and Licensing in the Governance of Human Genome Editing
01/06/2021
1 Media contribution
Press/Media: Press / Media
Interview with Danish Radio (DR) on compulsory licensing issues
12/02/2021
1 Media contribution
Press/Media: Press / Media
Key takeaways from IAM’s 2020 Pharma and Biotech IP event
06/02/2020
1 Media contribution
Press/Media: Press / Media
LSPN Europe 2017: Broad had ‘no clue’ about CRISPR licensing in agriculture
07/12/2017
1 Media contribution
Press/Media: Press / Media
Locus licenses CRISPR tech to Janssen in potential $818m deal
09/01/2019
1 Media contribution
Press/Media: Press / Media
ID: 16150437
Most downloads
-
4344
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 1: – Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2234
downloads
The Evolution of the CJEU’s Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2093
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 2: Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published